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Bacterial responses to antibiotics are concentration-dependent. At high concentrations,
antibiotics exhibit antimicrobial activities on susceptible cells, while subinhibitory con-
centrations induce diverse biological responses in bacteria. At non-lethal concentrations,
bacteria may sense antibiotics as extracellular chemicals to trigger different cellular
responses, which may include an altered antibiotic resistance/tolerance proﬁle. In natural
settings, microbes are typically in polymicrobial communities and antibiotic-mediated
interactions between species may play a signiﬁcant role in bacterial community structure
and function. However, these aspects have not yet fully been explored at the community
level. Here we discuss the different types of interactions mediated by antibiotics and
non-antibiotic metabolites as a function of their concentrations and speculate on how
these may amplify the overall antibiotic resistance/tolerance and the spread of antibiotic
resistance determinants in a context of polymicrobial community.
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INTRODUCTION
Antibiotics are bioactive small molecules naturally produced by
secondary metabolism of microorganisms such as bacteria and
fungi (Davies, 2006; Aminov, 2010; Davies and Davies, 2010).
Their discovery as antimicrobial drugs has revolutionized the
management and treatment of infectious diseases. Many easily
treated infectious diseases today had high mortality rates in the
pre-antibiotic era. However, due to the increasing prevalence of
resistance, the in vivo efﬁcacy of antibiotics is reduced or abolished,
and the spread of antibiotic-resistant microorganisms is now
threatening the treatment of otherwise manageable infections.
Antibiotic resistance in microbes is widespread and it has been
demonstrated that soil bacteria are rich in resistance determi-
nants to both natural and synthetic antibiotics commonly used in
clinics (D’Costa et al., 2006). The collective genes that contribute
to antibiotic resistance are referred to as the antibiotic resistome
(D’Costa et al., 2007; Wright, 2007). Interestingly, antibiotic resis-
tance genes extracted from the soil resistome were shown to be
identical or highly similar to those found in clinically relevant
drug-resistant human pathogens (Forsberg et al., 2012) demon-
strating that lateral gene transfer likely plays a role in the rise of
multidrug-resistant pathogens. In addition to the environment,
the human microbiome is also a niche rich in antibiotic resistance
determinants where exchange of resistance genes can lead to the
generation of drug-resistant bacteria with potential pathogenic
traits (Sommer et al., 2009, 2010; Sommer and Dantas, 2011).
Altogether, these recent studies showed that the spread of antibi-
otic resistance from non-pathogenic environmental bacterial is
an ongoing threat to the clinical use of antibiotics, even for new
synthetic compounds, and the emergence of new drug-resistant
pathogens is a constant threat.
Despite a better understanding of the different mechanisms
leading to resistance, exposure to antibiotics is still considered the
major driver in the selection for antibiotic-resistant bacteria (Levy,
2001; Marshall and Levy, 2011; Andersson and Hughes, 2012)
and the selection occurs over a large spectrum of concentrations
(Andersson and Hughes, 2012). Lethal concentrations of antibi-
otics rarely occur outside of therapeutic applications, but bacteria
constantly face subinhibitory antibiotics in the environment and
the host (e.g., human and other animals) following therapies. In
fact, the release of antibiotics in the environment from medical
or non-medical (e.g., agricultural) use artiﬁcially creates concen-
tration gradients that are rarely encountered by environmental
bacteria located in areas that are normally free of human-derived
antibiotic activities (Aminov, 2009; Martinez, 2009a). The rapid
appearance of drug-resistant bacteria upon antibiotic exposure
implies that resistance and resistancemechanisms have co-evolved
with antibiotic-derived products. The latter point raises the ques-
tion as to whether antibiotic resistance was already a bacterial trait
before themodern use of antibiotics. To address this question, ele-
gant metagenomic and functional studies showed the existence of
resistance determinants in pristine areas of the world (D’Costa
et al., 2011; Bhullar et al., 2012) demonstrating that antibiotic
resistance predates the clinical use of antibiotics. Therefore, antibi-
otic resistance is a common bacterial feature. The medical and
non-medical use of antibiotics may accelerate the spread of resis-
tance through positive selection in both the environment and
the host.
The focus on the medical use of antibiotics has limited fun-
damental research regarding the other potential activities of these
compounds in their natural settings, including the environment
(e.g., soil) and hosts such as humans, animals, and plants. In
complex communities containing antibiotic-producing microor-
ganisms, bacteria are naturally exposed to lethal and non-lethal
antibiotics making them trained at responding to these com-
pounds. Non-lethal levels of antibiotics can alter the expression of
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genes involved in a variety of bacterial functions like metabolism,
regulation, virulence, DNA repair, and stress response (Goh
et al., 2002; Tsui et al., 2004; Davies et al., 2006; Yim et al., 2006,
2007, 2011; Blazquez et al., 2012). Subinhibitory antibiotics can
also modify cellular behaviors in bacteria with the formation of
bioﬁlms (Hoffman et al., 2005; Frank et al., 2007; Haddadin et al.,
2010;Mirani and Jamil, 2011; Subrt et al., 2011; Kaplan et al., 2012)
and persister cells (Dorr et al., 2010). Altogether, these observa-
tions strongly suggested that antibiotics induce responses other
than those associated to their antimicrobial activities and it is
now accepted that they might be used as “signaling” molecules
with regulatory functions (Yim et al., 2007; Aminov, 2009; Allen
et al., 2010).
Antibiotics are, like other bioactive smallmolecules, lowmolec-
ular weight metabolites produced by secondary metabolism of
microorganisms, i.e., are not considered essential for growth and
viability. Microorganisms such as bacteria and fungi produce
a wealth of small molecules that has been called the parvome
(Davies, 2009; Davies and Ryan, 2012). Secondary metabolites
are responsible for most of the interactions taking place in nat-
ural microbial communities (Lyon and Muir, 2003; Keller and
Surette, 2006; Duan et al., 2009; Rath and Dorrestein, 2012) and as
extracellular metabolites antibiotics have the potential to exhibit
similar functions. Bacteria in natural environments are mostly
part of complex polymicrobial communities in which all members
share nutrient resources as well as chemicals including primary
metabolic endproducts and secondarymetabolites,whichhave the
potential to induce antibiotic resistance/tolerance mechanisms.
Natural communities also include host-associated communities
such as the human microbiome. The role(s) of antibiotics in
mediating non-lethal interactions between bacterial cells, may
in fact, play a much bigger role than previously anticipated in
the global antibiotic resistance threat that we are currently fac-
ing. Naturally occurring antibiotics, and other related secondary
metabolites in bacterial communities, may dictate the spread of
antibiotic resistance in a concentration-dependentmanner. There-
fore improving our current knowledge of antibiotic-mediated
interactions in bacteriamay facilitate the development of new ther-
apeutic strategies for the treatment of drug-resistant pathogens.
Here we review the current knowledge of antibiotic responsive
activities as a function of their concentrations and speculate on
how these antibiotic-mediated interactions may overall inﬂuence
antibiotic resistance/tolerance and community composition in
heterogeneous polymicrobial communities.
CHEMICAL INTERACTIONS
The explosion of research in cell–cell interactions mediated by
bioactive small molecules in microbiology has led to the general
assumption that most interspecies cell–cell interactions could be
labeled as “communication” or “signaling.” However, it is impor-
tant to note that the demonstration of a biological response
upon exposure to a chemical does not necessarily imply com-
munication. The improper use of terms like signal, signaling,
or communication in microbiology has created confusion since
most interspeciesmetabolite-mediated interactions labeled as“sig-
naling/communication” are often in conﬂict with evolutionary
theories. A detailed analysis of the appropriate terminology is
beyond the scope of this review; therefore we refer the reader
to recent reviews that have thoroughly discussed the topic (Keller
and Surette, 2006; Diggle et al., 2007; Stacy et al., 2012). A chemi-
cal mediating intra- or interspecies interactions can be deﬁned as
a signal, cue, or coercion (chemical manipulation). For a chem-
ical interaction to occur, emitting bacteria must ﬁrst produce a
molecule that can be perceived by other individuals, and second,
the receiver must alter its behavior in response to the signal.
To determine whether an interaction is mediated by a signal,
a cue, or coercion the overall beneﬁt of the reaction is used as
primary criteria. As shown in Table 1, a signal is deﬁned when
both partners take advantage of the interaction (bidirectional),
while cues or coercions have unidirectional beneﬁts for receivers
or emitters, respectively. In true signaling interactions, the pro-
duction and detection of the signal have co-evolved speciﬁcally
for that purpose and from an evolutionary perspective these events
will only bemaintainedwhen both partners beneﬁt from the infor-
mation conveyed by the signal for which they evolved (Maynard
Smith and Harper, 2003; Keller and Surette, 2006). On the other
hand, a cue provides information to a receiver for which a response
is triggered (Keller and Surette, 2006; Diggle et al., 2007; Stacy et al.,
2012). Although not mediated by single molecules, environmen-
tal conditions can also be considered as cues by bacteria and they
include pH, osmolarity, temperature, oxidative stress/oxygen, and
nutrient limitation. The main distinction with a signal is that the
biological response did not evolve for that purpose, which beneﬁts
only the receiver (Keller and Surette, 2006; Diggle et al., 2007; Stacy
et al., 2012). Conversely, a coercion scenario is a strategy used by
the emitter, via the release of a molecule, to chemically manipulate
the receiver for its own beneﬁt (Keller and Surette, 2006; Diggle
et al., 2007; Stacy et al., 2012).
Figure 1 illustrates the different ways by which a single chem-
ical can be perceived by bacterial cells of different species within
a polymicrobial community. Although interactions mediated by
signals, cues, or coercions can all occur in these communities, the
majority of these dynamic interactions fall in the category of cue,
because they do not require stability over time, for which only
receiver cells evolve. The modulation of Pseudomonas aeruginosa
virulence factors by autoinducer-2 (AI-2) from the oropharyn-
geal microbiota (Duan et al., 2003) and alteration of the antibiotic
tolerance proﬁle by volatile ammonia (Bernier et al., 2011) are
examples of interspecies interactions mediated by cues.
Interestingly, intraspecies diversitymay in some cases challenge
the concept of true communication by the rise of cheaters through
Table 1 | Simplified description of chemical-mediated interactions1,2.
Benefits the emitter Benefits the receiver
Signal ++ +
Cue − +
Coercion + −
1The overall beneﬁt is used as the main determinant for the classiﬁcation of the
different types of bacteria–bacteria interactions and are either beneﬁcial (+) or
costly (−).
2Adapted from Diggle et al. (2007) and Stacy et al. (2012).
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FIGURE 1 | A single chemical mediates different bacteria–bacteria
interactions in a context of a polymicrobial community.The schematic
represents how a single chemical released by one bacterial species can be
perceived differently in a multispecies community. Microorganisms that
beneﬁt positively (blue) or negatively (brown) from the different interaction
are represented. Arrows indicate direction of evolved pathway, e.g., an
organism evolves to “sense” a cue or in some case can use an antibiotic as
a nutritional source (Dantas et al., 2008). In the case of signaling and
interspecies signaling, pathways from both producer and receiver cells
have co-evolved to the beneﬁt of both microorganisms. In the case of
coercion or toxic interactions such as those exhibited by antibiotics, only
the producer beneﬁts from the interaction.When the producer itself
detects the signal, this would be a case of quorum sensing or cell–cell
signaling. In the case of antibiotics, the producer usually co-expresses
resistance pathways and these can be co-expressed without a sensing
circuit but often, such as with many lantibiotics, they are detected by the
cell and respond in a classical quorum sensing feedback loop.
genetic mutations. The inability of cheaters to either produce
and/or perceive a signal may abolish the bidirectional coopera-
tive interaction. In a situation where the response toward a signal
leads to the production of a protease allowing the degradation of a
particular substrate for nutritional purposes, cheaters impaired in
either the production or the reception of a signal will differentially
impact the cooperative interaction. In fact, cheaters get a direct
competitive advantage by avoiding the metabolic cost of produc-
ing a signal or responding to it and their selﬁsh behavior allows
them to beneﬁt without being cooperative. However, some sys-
temsmay have co-regulated pathways that help to control cheaters
(Dandekar et al., 2012).
BIOACTIVITY AND ANTIBIOTIC RESISTANCE ARE DRIVEN BY
ANTIBIOTIC CONCENTRATIONS
Antibiotics are generally known for their antimicrobial proper-
ties by which they either kill (bactericidal) or inhibit bacterial
growth (bacteriostatic). Their concentrations are highly variable
in natural communities and bacteria have evolved mechanisms
to respond accordingly. Although their antimicrobial properties
have been demonstrated in both in vitro and in vivo settings, the
biological roles of antibiotics and antibiotic resistance in natural
environments are still undeﬁned.
To ﬁrst differentiate the biological responses induced by
antibiotics, here we represent their bioactivities from a receiver
bacterium’s perspective on a large concentration spectrum
(Figure 2). From high to low concentrations, antibiotics act
as either toxins, stress inducers, or as cues/coercions, respec-
tively. Among interactions mediated by subinhibitory antibiotics,
receiver bacteria can interestingly induce mechanisms leading
to antibiotic resistance or tolerance (Figure 2). How antibiotics
become stress inducers or cues/coercions will further be discussed
in the following sections, but before we will brieﬂy describe the
toxin-like behavior of antibiotics and the impact of antibiotic
resistance on the biological response exhibited by bacteria upon
antibiotic exposure.
At concentrations superior to or near the minimal inhibitory
concentration (MIC), antibiotics behave like toxins on suscep-
tible bacterial cells. However, although the understanding of
resistance mechanisms is well-characterized, molecular mech-
anism(s) induced by lethal concentrations of antibiotics is an
area of research where our fundamental understanding is still
very limited (Kohanski et al., 2010). Recent studies suggested that
antibiotic-induced cell death was associated with increased pro-
duction of radical oxygen species (ROS) such as hydroxyl radicals,
superoxide, and hydrogen peroxide for bactericidal antibiotics
belonging to the families of quinolones, β-lactams, and amino-
glycosides (Dwyer et al., 2007, 2009; Kohanski et al., 2007, 2008,
2010). Although antibiotic ROS-mediated killing is highly possible
in aerobic conditions, the proposed model is however, oxygen-
dependent (Hassett and Imlay, 2007) and other mechanisms must
operate in oxygen-poor environments such as those found in
bioﬁlm populations (Stewart and Franklin, 2008).
Antibiotic resistance mechanisms and the antimicrobial nature
of antibiotics are often associated as a cause and effect phe-
nomenon. The presence of resistance genes in bacteria with
antibiotic biosynthesis genetic loci (Benveniste and Davies, 1973;
Walker and Skorvaga, 1973; Davies and Benveniste, 1974) is an
obvious self-protective strategy (Martinez, 2009a,b; Davies and
Ryan, 2012;Wright and Poinar, 2012). It has therefore been widely
accepted that antibiotic resistance determinants have speciﬁcally
evolved to tolerate the lethal activity of antibiotics (Martinez,
2009a,b), but experimental data to fully support this thesis are
still lacking (Davies and Ryan, 2012). Antibiotics are mainly
present at non-lethal concentrations in the environment (Mar-
tinez, 2009a,b), therefore antibiotic resistance determinants are
likely involved in response mechanisms other than those required
when receiver bacteria are exposed to lethal concentrations. Simi-
lar to the antibiotic concentration-dependent response (Figure 2),
antibiotic resistance would also impact receiver bacteria in an
antibiotic dose-dependent manner. The presence of an antibi-
otic resistance mechanism would shift the spectrum of responses
to an antibiotic to higher concentrations. The resistance would
lower the effective concentration of antibiotics at the target site
(Figure 3A). Exceptions to this would occur if there were sec-
ondary target sites for the antibiotics thatmediate other responses.
At toxic concentrations, resistance would function in the con-
ventional protective role and allow receiver bacteria to avoid the
antibiotic toxicity by blocking death or growth arrest. At subin-
hibitory concentrations, antibiotic resistance genes would shift the
effective antibiotic concentration required for inducing the bio-
logical responses (stress inducers, coercion, and cues) of receiver
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FIGURE 2 | Biological responses toward antibiotics are concentration-
dependent. Bacterial interactions mediated by antibiotics induce biological
responses in receiver bacteria in a dose-dependent manner. The antimicrobial
behavior (toxin) of antibiotics occurs when their concentrations is high leading
to bacterial death or growth arrest in susceptible receiver cells. At lower
concentrations, subinhibitory, antibiotics can act as stress inducers, coercions
or be sensed as cues. Biological responses induced in receiver bacteria when
antibiotics are at subinhibitory concentrations can affect various cellular
responses or alter gene expression leading to different adaptive responses
impacting antibiotic resistance/tolerance.
bacteria (Goh et al., 2002; Yim et al., 2007; Mesak et al., 2008;
Mesak and Davies, 2009). The displacement of the response curve
to subinhibitory concentrations of antibiotics due to the presence
of resistance determinants (Figure 3A) could therefore establish
a chemical “arms race” between producer and receiver bacteria
independent of lethal effect. In the context of bacterial communi-
ties, the displacement of the response curve for a single strain will
modify its own behavior, whichmay in return shift the community
composition or activity. Stress induction, coercion, and detection
of cues are selectable phenotypes that can be tuned to meet the
conditions of natural environments. Selections that reduce stress
induction and coercion could be contributing factors in the evo-
lution of the “cryptic resistome” (Wright, 2007); genes that are
normally expressed at low levels or have low speciﬁc activity that
do not confer resistance to the toxic effects of antibiotics at higher
concentrations. These may be resistance genes tuned to environ-
ments where there are lower concentrations of these bioactive
molecules.
In natural environments, antibiotics are likely present in a
gradient of concentrations while receiver organisms may also be
heterogeneous. Even in a homogeneous clonal population, cells
may be present in different physiological states and the pres-
ence of antibiotic tolerance and resistance mechanisms will shift
the response curves for individual cells within the population
(Figure 3B). In the context of chemical interactions within natural
communities, antibiotics released by emitter bacteria at lethal
concentrations for the receiver cells would not be considered as
a signaling event, but rather coercion at the extreme. Coercion can
occur at subinhibitory concentrations and one bacterial cell may
use chemicals to manipulate another. If the receiver cell possesses
the corresponding antibiotic resistance determinant, receiver bac-
teria will be less susceptible to chemical manipulation and the
overall beneﬁt or harmof the interactionwill therefore be reduced.
Outside of the well-mixed homogeneous environments of lab-
oratory cultures, antibiotic effects on bacterial populations will
be heterogeneous. For any bacteria, the response to a speciﬁc
antibiotic will be concentration-dependent (Figure 2) and the
active concentration for a particular response will be shifted
higher by resistance mechanisms (Figure 3A). In natural environ-
ments, a population will be expected to exhibit a heterogeneous
response because of gradients of antibiotic concentration and
heterogeneity in the responsiveness of different cells in the pop-
ulation (Figure 3B). These differences in cellular responsiveness
may be due to genetic heterogeneity and/or through differences in
physiological states of different cells in the population.
ANTIBIOTICS AS STRESS INDUCERS
Antibiotics at subinhibitory concentrations can act as stress induc-
ers or cues/coercion on receiver bacteria (Figure 2). When
behaving as stress inducers, antibiotics often induce the SOS
stress response, which is also associated with various antibi-
otic resistance mechanisms. The following section will mainly
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FIGURE 3 | Biological role(s) of antibiotic resistance in natural
communities. (A)The response of bacterial cells to antibiotic whether it is
bactericidal/bacteriostatic or subinhibitory, the biological response (as a cue
or coercion) will be shifted by antibiotic resistance. (B) In natural
environments, differences in physiological states can impact the expression
of antibiotic resistance or tolerance mechanisms. Antibiotic concentrations
in these environments may also be distributed as gradients, meaning that
the population will not necessarily respond uniformly.
highlight some of the main resistance mechanisms impacted by
the induction of the SOS response in bacteria upon antibiotic
exposure.
Bacteria possess multiple survival mechanisms to cope with
exogenous stresses and the SOS response is the main general stress
response induced by bacteria in these situations (Galhardo et al.,
2007; Blazquez et al., 2012; Poole, 2012b). The SOS stress response
is typically induced upon DNA damage caused by extracellular
stresses such as bacterial cell exposure to UV light or antibiotics
(Erill et al., 2007; Janion, 2008; Butala et al., 2009). It is charac-
terized by a well-coordinated global response initiating inhibition
of cell division and induction of DNA repair, recombination, and
mutation (Erill et al., 2007; Janion, 2008; Butala et al., 2009). In
most bacterial species, the RecA and LexA proteins govern the
response, which is conserved across bacterial phyla with a few
exceptions where the LexA repressor protein homolog is absent,
such as in Streptococcus species (Erill et al., 2007). Upon DNA
damage, RecA stimulates cleavage of the LexA repressor leading to
the global response involving more than 40 SOS-regulated genes
(Courcelle et al., 2001; Erill et al., 2007; Janion, 2008; Butala et al.,
2009). For a more comprehensive description of the SOS stress
response, we refer the reader to consult some of these reviews that
have thoroughly discussed the topic (Erill et al., 2007; Janion, 2008;
Butala et al., 2009).
Fluoroquinolones and quinolones are broad spectrum antibi-
otics, for which resistant mechanisms have quickly emerged (Ruiz,
2003). They inhibit DNA gyrase leading to double-stranded DNA
breaks and consequently induction of the SOS stress response
(Urios et al., 1991; Dwyer et al., 2007; Yim et al., 2011). This
induction usually occurs within a particular window of antibi-
otic concentrations (Piddock and Wise, 1987). In addition to
ﬂuoroquinolones or quinolones, bactericidalβ-lactamand amino-
glycoside antibiotics mediate bacterial killing by stimulating the
production of ROS (Dwyer et al., 2007, 2009; Kohanski et al.,
2007, 2008, 2010), which are themselves potent DNA damaging
molecules (Farr and Kogoma, 1991). Consequently, all antibi-
otics mediating the production of ROS would therefore have
the potential to induce the SOS stress response. Interestingly,
ﬂuoroquinolone and β-lactam antibiotics were shown in multi-
ple studies to induce the SOS stress response in Escherichia coli
while aminoglycosides failed (Ysern et al., 1990; Miller et al., 2004;
Baharoglu and Mazel, 2011; Poole, 2012b). The intimate rela-
tionship between ROS-mediated killing and SOS-induction by
bactericidal antibiotics requires more investigations to explain
these discrepancies, but it does suggest that the stimulation of
ROS production upon antibiotic exposure may be an indirect
effect. Parallel mechanisms to the SOS response may exist for
aminoglycosides to kill bacteria in a ROS-dependent manner or
concentrations must be lethal to induce the SOS response and not
subinhibitory. Other antibiotic classes represented by trimetho-
prim, ceftazidime, and sulfamethoxazole are also strong inducers
of the SOS stress response in E. coli (Blazquez et al., 2012).
The SOS stress response is widespread among bacteria (Erill
et al., 2007), but differences in the antibiotic SOS-induction
proﬁles have been observed between species. For example, subin-
hibitory concentrations of tetracycline, chloramphenicol, and
aminoglycosides induce the SOS response of Vibrio cholerae, while
these antibiotics have no impact in E. coli (Baharoglu and Mazel,
2011). Despite the strong similarities between SOS systems across
Gram-negative bacteria and the genetic relatedness of E. coli and
V. cholerae, these disparities suggest that antibiotics may not nec-
essarily induce the SOS response directly from DNA damage,
but rather via upstream pathways or targets of the SOS response
(Aertsen andMichiels, 2006) that could potentially differ between
bacterial species. These differences between bacterial species may
reﬂect the evolutionary selective pressure on the different bac-
teria with speciﬁc features reﬂecting conditions of their natural
environments.
The induction of the SOS response is often essential for
bacterial survival in stressful environments and associated with
genetic responses that indirectly alter antibiotic resistance by
increasing mutation rate, horizontal gene transfer, and prophage
induction (Erill et al., 2007; Janion, 2008; Butala et al., 2009;
Dwyer et al., 2009). Several studies have shown that induction
of the SOS response by various antibiotics like ﬂuoroquinolones,
β-lactams, trimethoprim, tetracycline, chloramphenicol, rifampi-
cin, and aminoglycosides increased the mutation frequency in dif-
ferent bacterial species (Ysern et al., 1990; Gillespie et al., 2005;
Henderson-Begg et al., 2006; Cortes et al., 2008;Mesak andDavies,
2009; Baharoglu and Mazel, 2011; Yim et al., 2011). Induction
of competency by ﬂuoroquinolones leading to horizontal gene
transfer with the potential to acquire new antibiotic resistance
determinants has recently been reviewed (Charpentier et al., 2012).
Furthermore, antibiotics inducing the SOS response can promote
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bacterial genetic diversity via homologous recombination, phage
release, and transfer of integrons or conjugative elements (Matic
et al., 1995; Beaber et al., 2004; Cirz et al., 2007; Hocquet et al.,
2012) all involved in the movement of mobile DNA like antibiotic
resistance genes.
The induction of the SOS response is critical and relevant to our
understanding of antibiotic-mediated interactions on the overall
impact of antibiotic resistance in bacterial populations. Bacteria
in most environments including those affected during therapeutic
treatments can potentially encounter subinhibitory concentra-
tions of antibiotics inducing the SOS stress response. Therefore, a
better understanding of SOS-associated behaviors linked to antibi-
otic resistance traitsmay result in alternative approaches to control
their spread.
ANTIBIOTICS AS CUES
Various antibiotics at subinhibitory concentrations induce bio-
logical responses on receiver bacteria that are non-stress-related
and frequently affect pathways of primary metabolism (Goh et al.,
2002; Tsui et al., 2004; Davies et al., 2006; Yim et al., 2006, 2007,
2011; Blazquez et al., 2012). Here we highlight examples demon-
strating bacterial interactions mediated by antibiotics sensed as
cues, which can subsequently impact the antibiotic resistance pro-
ﬁle of receiver bacteria. These inducible responses can directly
target mechanisms leading to speciﬁc antibiotic resistance or
indirectly impact tolerance toward various antibiotics.
Many bacteria can sense speciﬁc antibiotics in their envi-
ronment and subsequently induce the corresponding resistance
mechanisms. Tetracycline and vancomycin are the two best-
studied examples. Tetracycline resistance has been attributed to
classical resistance mechanisms including efﬂux strategies, target
site access (TetM and TetO), and chemical inactivation (TetX; Nel-
son and Levy, 2011). The regulation of some tetracycline resistance
determinants is under the control of tetracycline repressor protein
(TetR), which has been thoroughly reviewed elsewhere (Hillen
and Berens, 1994; Berens and Hillen, 2003; Ramos et al., 2005;
Nelson and Levy, 2011). Brieﬂy, TetR has DNA binding domains
targeting operators of tetracycline resistance genes. Once bound
to the operator region of a target gene, TetR acts as a transcrip-
tional repressor for which the repression can be relieved by the
interaction of tetracycline with TetR (Hillen and Berens, 1994;
Berens and Hillen, 2003; Ramos et al., 2005). Therefore, when
tetracycline is present, the repressive function of TetR is abolished
and transcription of the tetracycline resistance gene can occur
normally.
In the case of vancomycin, modiﬁcation of the target (pepti-
doglycan – D-Ala-D-Ala C-terminus) is the primary mechanism
of resistance (Courvalin, 2006). Six types of resistance to van-
comycin (VanA, B, C, D, E, and G) were reported in Enterococcus
species (Courvalin, 2006). Interestingly, four of these operons
involved in vancomycin resistance (VanA, B, E, and G) are directly
inducible by vancomycin, while VanG and C types are constitu-
tive (Courvalin, 2006). Vancomycin is sensed by a two-component
regulatory system that positively activates expression of resistance
genes in response to vancomycin. Although the basic regulation
differs between tetracycline and vancomycin resistance genes, the
inducible nature of their speciﬁc resistance pathways demonstrate
that antibiotics have the ability to directly induce targeted and
speciﬁc resistance mechanisms.
Although subinhibitory concentrations of antibiotics like tetra-
cycline and vancomycin can induce their own resistance mecha-
nisms, other biological responses have the potential to indirectly
impact antibiotic tolerance as well. It was recently demonstrated
that subinhibitory concentrations of β-lactam antibiotics induce
the autolysin-dependent release of extracellular DNA (eDNA) by
Staphylococcus aureus. This affects bioﬁlm formation and autoag-
gregation (Kaplan et al., 2012), two growth protectivemechanisms
that will be discussed in the following section. Interestingly, eDNA
that is part of the extracellular matrix of P. aeruginosa bioﬁlms
induces tolerance against aminoglycosides by chelating cations
(Mulcahy et al., 2008). Additionally, subinhibitory concentra-
tions of antibiotics like vancomycin, tetracycline, azithromycin,
and ampicillin induce the expression of P. aeruginosa virulence-
associated genes leading to increased secretion of phenazines and
rhamnolipids (Shen et al., 2008). Pyocyanin, one of the four P.
aeruginosa phenazines (Price-Whelan et al., 2006) was recently
showed to induce eDNA release in P. aeruginosa bioﬁlms through
hydrogen peroxide (H2O2) mediating cell lysis (Das and Mane-
ﬁeld, 2012). These examples provide evidence that in multispecies
communities, subinhibitory antibiotics can lead to a series of
sequential responses leading to antibiotic tolerance (Figure 4).
These are a few examples demonstrating that sensing of subin-
hibitory concentrations of antibiotics as cues can trigger direct or
indirectmechanisms, for which receiver bacteria will subsequently
have the ability to resist or tolerate lethal concentrations of antibi-
otics. In microbial communities, the response of one organism
may lead to induction of antibiotic resistance/tolerance in other
bacteria.
FIGURE 4 | Antibiotic induction of extracellular DNA (eDNA) release in
a multispecies community and antibiotic tolerance.The schematic
represents how two bacterial species, P. aeruginosa (green) and S. aureus
(purple), respond to subinhibitory antibiotics to release eDNA. Subinhibitory
antibiotics induced the production of pyocyanin (Shen et al., 2008), which is
associated with increased H2O2 levels responsible for cell lysis and DNA
release (Das and Maneﬁeld, 2012). In S. arureus, exposure to subinhibitory
β-lactam antibiotics induces release of eDNA via an autolysis-dependent
mechanism (Kaplan et al., 2012). The release of eDNA by both bacteria can
induce antibiotic tolerance in communities (Mulcahy et al., 2008).
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ANTIBIOTICS AS INDUCERS OF GROWTH PROTECTIVE
MECHANISMS
A signiﬁcant portion of the antibiotic resistome is made of mobile
resistance genes that are horizontally transferable between bacte-
rial cells (D’Costa et al., 2007; Wright, 2007; Allen et al., 2010).
Mobile resistance determinants as well as efﬂux pumps account
for the majority of antibiotic resistance mechanisms, however,
bacteria have evolved non-inherited and transient mechanisms
to resist otherwise lethal antibiotic concentrations (Levin and
Rozen, 2006). Environmental conditions can trigger various stress
responses making bacterial cells transiently refractory to antibi-
otics. Bacterial stress responses as determinants of antibiotic
resistance have become an emerging area of research. For a more
comprehensive description of these we refer the reader to recent
reviews that have thoroughly addressed the topic (Poole, 2012a,b).
Brieﬂy, bacterial exposures to environmental-related stresses like
nutrient starvation/limitation (nutrient stress), ROS and reactive
nitrogen species (oxidative/nitrosative stress), membrane damage
(envelope stress), temperature (heat/cold stress), and ribosome
disruption (ribosomal stress) have the potential to initiate bacte-
rial responses leading to modiﬁed or enhanced tolerance toward
the lethal action of antibiotics (Poole, 2012a,b).
Non-inherited and transientmechanisms aremainly attributed
to two distinct processes: persistence and drug indifference (Levin
and Rozen, 2006). While persistence occurs in subpopulations of
slow or non-growing bacteria, drug indifference can be exhibited
by the entire population (Levin andRozen,2006). Persister cells are
generally considered to be responsible for bacterial survival follow-
ing antibiotic treatments although heterogeneity within bacterial
populations and reduced accessibility of the drug to some target
cells also contribute. A comprehensive description of persister cells
is beyond the scope of this review; therefore we refer the reader
to recent reviews that have thoroughly discussed the topic (Lewis,
2007,2010,2012; Gerdes andMaisonneuve,2012; Kint et al., 2012).
Persisters are phenotypic variantswithin an isogenic bacterial pop-
ulation that can tolerate high concentrations of antibiotics. In
contrast to drug-resistant cells, persisters can switch back to the
wild-type antibiotic sensitive phenotype when reactivated (Lewis,
2007,2010,2012; Gerdes andMaisonneuve,2012; Kint et al., 2012).
This persister cell behavior has been directly observed (Balaban
et al., 2004). Persisters are present both in planktonic bacteria and
antibiotic-tolerant bioﬁlms (Spoering and Lewis, 2001). Research
emphasis in the ﬁeld has largely focused on mechanisms involved
in persister formation and mechanisms leading to their forma-
tion have been proposed such as stochastic processes (passive) to
active inducible regulation (Kint et al., 2012). Stochastic switching
has been proposed as an effective strategy for survival in unpre-
dictable environments (Kussell and Leibler, 2005; Kussell et al.,
2005). Dormancy is a passive mechanism involved in persister
formation resulting from stochastic endogenous stress leading to
growth arrest and the shutdown of bactericidal antibiotic tar-
gets making persisters multidrug-tolerant cells (Lewis, 2007, 2010,
2012). Experimental evidence to support the dormancy theory
came from transcriptome analysis showing that genes involved in
primary metabolism and energy production were down-regulated
in persister cells (Keren et al., 2004; Shah et al., 2006). However,
the dormancy model was challenge when persisters of E. coli were
demonstrated to display some level of protein translation (Gefen
et al., 2008).
Active mechanisms leading to the induction of persisters in
bacterial populations differ in terms of target. After the iden-
tiﬁcation of hipA, as the ﬁrst persistence gene and coding for
the toxin of the hipAB toxin–antitoxin module (TA; Moyed
and Bertrand, 1983), many studies have shown that differ-
ent TA modules were involved in bacterial persistence (Lewis,
2010, 2012; Gerdes and Maisonneuve, 2012; Kint et al., 2012).
The induction of toxin genes in persister cells (Keren et al.,
2004; Shah et al., 2006) or the overexpression of toxins lead-
ing to increased persistence (Keren et al., 2004; Shah et al.,
2006; Harrison et al., 2009; Maisonneuve et al., 2011) supported
the role of TA modules in bacterial persistence. Interestingly,
the ﬂuoroquinolone ciproﬂoxacin was shown to induce bacte-
ria persistence via the TA module TisAB upon activation of
the SOS response (Dorr et al., 2010). Consistently, lethal con-
centrations of ampicillin or oﬂoxacin induce the SOS stress
response in persister cells (Kaldalu et al., 2004) while the SOS
response confers persistence to ﬂuoroquinolones (Dorr et al.,
2009). Unrelated to TA modules, the extracellular chemical
indole was recently shown as mechanism inducing persisters in
E. coli populations (Vega et al., 2012). Interestingly, the latter
represents a non-antibioticmediated interaction leading to antibi-
otic tolerance; a topic that will be discussed in the following
section.
Beside unicellular growth, bacteria can also adopt various
types of multicellular growth that exhibit phenotypes different
than their planktonic counterparts including antibiotic tolerance.
Multicellular behaviors in bacteria include growth as bioﬁlms,
aggregates, and swarming. Bioﬁlms are sessile bacterial cells
encased within an extracellular matrix that are usually attached
to a surface (Stewart and Franklin, 2008; Monds and O’Toole,
2009). Bacterial aggregates are described as unattached bioﬁlm-
like structures with the ability tomove (Alhede et al., 2011; Haaber
et al., 2012; Thornton et al., 2012) while swarming represents a
type of motility exhibited by bacteria over semi-solid surfaces
(Kearns, 2010). These multicellular behaviors were all associ-
ated with elevated tolerance to lethal concentrations of antibiotics
when compared to their planktonic counterparts (Stewart and
Costerton, 2001; Kim et al., 2003; Lewis, 2007; Overhage et al.,
2008; Lai et al., 2009; Alhede et al., 2011; Haaber et al., 2012;
Thornton et al., 2012). These studies demonstrate that multi-
cellular assemblies in bacteria confer an advantage when facing
antibiotics compared to planktonic cells. However, the growth
phase of planktonic cells (i.e., logarithmic or stationary) can
have a signiﬁcant impact on their antibiotic tolerance proﬁles.
For example, planktonic P. aeruginosa and E. coli cells were
previously shown to exhibit greater levels of tolerance against
bactericidal antibiotics (Evans et al., 1991; Spoering and Lewis,
2001; Bernier et al., 2013). In Salmonella typhimurium shifts
in primary metabolic pathways have been associated with the
induced antibiotic tolerance in swarm cells (Kim and Surette,
2003, 2004; Turnbull and Surette, 2008, 2010) and aggregates
(White et al., 2010).
Antibiotic-mediated interactions impact multicellular behav-
iors and indirectly the antibiotic tolerance proﬁle of these
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populations. Several studies have showed that subinhibitory
antibiotics induce bioﬁlm formation (Hoffman et al., 2005; Frank
et al., 2007; Haddadin et al., 2010; Mirani and Jamil, 2011; Subrt
et al., 2011; Kaplan et al., 2012) and autoaggregation (Kaplan et al.,
2012). Bacterial response to extracellular stresses (Poole, 2012a,b)
may also be an important trigger of multicellular behaviors in
bacteria (Kaplan, 2011), which are better adapted as a group
due to their physiology to tolerate lethal antibiotics (Stewart and
Franklin, 2008). In support of this hypothesis, a recent study
showed that non-starving planktonic cells were generally more
tolerant to bactericidal antibiotics than bioﬁlms, but when these
same bacterial cells were starved, therefore stressed, bioﬁlm bac-
teria were signiﬁcantly more resilient to antibiotics than their
planktonic counterparts (Bernier et al., 2013). As one of the ﬁrst
responses to stress, the SOS response is signiﬁcantly more induced
in bioﬁlm cells compared to their planktonic counterparts (Beloin
et al., 2004; Bernier et al., 2013). The higher intrinsic level of SOS
in bioﬁlms may explain their increased mutation frequency com-
pared to planktonic cells (Conibear et al., 2009). Altogether, the
increased SOS-dependent mutation rate observed in bioﬁlms may
well explain the high level of genetic variants arising in bioﬁlm
populations in a RecA-dependent manner (Boles et al., 2004; van
der Veen and Abee, 2011) with the potential to impact antibiotic
resistance (Boles and Singh, 2008).
The unique physiology of multicellular behaviors such as
bioﬁlms and swarming bacteria may render these cells better
adapted to respond and tolerate extracellular stresses such as oth-
erwise lethal antibiotic concentrations, these statesmay be induced
directly by subinhibitory antibiotics.
NON-ANTIBIOTIC SMALL MOLECULES AS MODULATORS OF
ANTIBIOTIC TOLERANCE
We have highlighted previous studies demonstrating that bacteria
can sense antibiotics as cues to mediate bacteria–bacteria inter-
actions with the potential to induce resistance/tolerance when
lethal concentrations are subsequently reached. These can induce
antibiotic speciﬁc mechanisms (e.g., tetracycline, vancomycin)
or more general mechanisms like bioﬁlms induction. However,
the induction of antibiotic resistance/tolerance via cues is not
limited to antibiotics. Within natural communities, bacteria are
continuously exposed to a variety of small molecules other than
antibiotics. Among these bioactive metabolites, some have been
shown to induce biological responses in bacteria leading to a
change in the overall antibiotic tolerance proﬁle.
Bacterial-derived extracellular metabolites such as indole,
hydrogen sulﬁde (H2S),and volatile ammoniawere recently shown
to impact the antibiotic tolerance proﬁle of receiver bacteria (Lee
et al., 2010; Bernier et al., 2011; Shatalin et al., 2011; Vega et al.,
2012). Interestingly, all of these bioactive molecules have the abil-
ity to be soluble or volatile, however, only ammonia was studied
under its gaseous phase (Bernier et al., 2011).
Indole, a tryptophan-derived aromatic heterocyclic organic
compound, was recently reported to induce antibiotic resistance
in E. coli (Lee et al., 2010; Vega et al., 2012). A community-based
antibiotic resistancemechanismwas demonstrated to occur via the
release of the metabolite in continuous cultures of E. coli exposed
to increasing levels of the norﬂoxacin quinolone (Lee et al., 2010).
Brieﬂy, under antibiotic stress, a few drug-resistant mutants arise
and then release the metabolite indole that is sensed by the entire
population allowing other less resistant isolates to survive (Lee
et al., 2010). In this particular case, the overall population MIC
is totally biased by a few resistant clones since the majority of
isolates are sensitive (Lee et al., 2010). The altruistic behavior of
drug-resistant isolates comes with a ﬁtness cost, associated with
the production of indole, that beneﬁts the entire population (Lee
et al., 2010). Increased antibiotic tolerance mediated by indole is
proposed to result from induction of efﬂux pumps and oxida-
tive stress protective mechanisms (Lee et al., 2010). In a different
study, indole is proposed to directly induce persistence through
the generation of persister cells (Vega et al., 2012). The generation
of persisters by indole exposure is dependent on the phage-shock
(Psp) and OxyR pathways (Vega et al., 2012). In other studies,
indole was shown to promote the establishment of E. coli in dual-
species cultures with P. aeruginosa by inhibiting production of
pyocyanin and other P. aeruginosa virulence factors regulated by
quorum sensing (Chu et al., 2012). This example represents an
example of coercion in which E. coli-derived indole manipulates
P. aeruginosa as a strategy to colonize and share a polymicro-
bial community. Conversely, over production of indole through
the induction of ROS production by subinhibitory concentra-
tions of antibiotics was shown to impair E. coli bioﬁlm formation
(Kuczynska-Wisnik et al., 2010).
Until recently, the production of extracellular H2S by bacteria
has mainly been considered as a toxic by-product of metabolism.
However, bacterial-derived H2S is protective against the lethal
action of antibiotics in a ROS-dependent manner (Shatalin et al.,
2011). It was also demonstrated that endogenous nitric oxide
(NO) of Gram-positive bacteria was protective against oxida-
tive stress-mediated killing by macrophages (Shatalin et al., 2008)
and antibiotics (Gusarov et al., 2009). Interestingly, NO and H2S
act synergistically since the absence of one can be compensated
for by the increased production of the other one upon antibi-
otic exposure (Shatalin et al., 2011). These studies demonstrate
the biological relevance of bacterial gases in mediating bacterial
interactions and their indirect impact on antibiotic resistance.
Ammonia, a general by-product of amino acid catabolism, was
recently shown to modulate the antibiotic tolerance of neigh-
boring bacterial cells (Bernier et al., 2011). Brieﬂy, both Gram-
negative and Gram-positive bacterial species were able to tolerate
otherwise lethal concentrations of ampicillin and tetracycline
upon exposure to biogenic volatile ammonia (Bernier et al., 2011).
Conversely, sensitivity toward aminoglycoside antibiotics was
increased in bacterial cells exposed to volatile ammonia (Bernier
et al., 2011). Ammonia-mediated interactions between bacterial
cells were shown to induce the intracellular levels of polyamines
(Bernier et al., 2011). Consistently, addition of polyamines (sper-
midine and putrescine) could recapitulate the ammonia-mediated
phenotype demonstrating that the modiﬁed antibiotic tolerance
proﬁle of receiver bacteria was fully dependent on the polyamine
modulon upon ammonia exposure (Bernier et al., 2011). Interest-
ingly, it was demonstrated in Bacillus spp. that bioﬁlm formation
could also be induced upon exposure to biogenic ammonia and
polyamines were critical for normal bioﬁlm development (Burrell
et al., 2010; Nijland and Burgess, 2010).
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The close relationship between ammonia sensing, polyamine
induction, and bioﬁlm formation demonstrate that bacterial
interactions mediated by non-antibiotic molecules can modu-
late antibiotic tolerance not only locally, but also at a distance
when ammonia is under its gaseous phase. Altogether, non-
antibiotic-mediated interactions clearly demonstrate the complex-
ity of dealing with antibiotic resistance/tolerance when bacteria
are part of complex communities, making antibiotic treatments
unpredictable.
METABOLITE-MEDIATED INTERACTIONS IN BACTERIAL
COMMUNITIES AS MECHANISMS OF ANTIBIOTIC
RESISTANCE EVOLUTION
Many infections are polymicrobial and as presented above, antibi-
otics and non-antibiotic metabolites can mediate interactions
between organisms that may impact their efﬁcacy as antimicro-
bials. The following describes a hypothetical scenario demonstrat-
ing how metabolite-mediated interactions may have the potential
to alter the antibiotic resistance proﬁle of an entire population and
possibly leading to the spread of antibiotic resistance.
For this exercise, we chose a simple polymicrobial commu-
nity including the pathogens P. aeruginosa and S. aureus as well
as Streptococcus species belonging to the normal oropharyngeal
microbiota. These bacterial species can simultaneously co-infect
the lungs of cystic ﬁbrosis (CF) patients (Sibley et al., 2008b, 2009,
2011) and dynamic interactions between these organisms have
previously been demonstrated to alter P. aeruginosa virulence
(Duan et al., 2003; Sibley et al., 2008a). In the scenario described
below, we suggest that a single antibiotic therapy may affect
the overall community structure and subsequently the antibiotic
resistance of the community by initiating a cascade of inter-
species interactions mediated by antibiotics and non-antibiotic
metabolites (Figure 5).
Following an antibiotic treatment, many of the bacterial cells
in the community will lyse releasing their intracellular content
including eDNA and NO that could potentially induce antibiotic
tolerance (Mulcahy et al., 2008; Gusarov et al., 2009). However,
because of the population heterogeneity in terms of susceptibility
and resistance/tolerance (persisters, stationary phase cells, aggre-
gates, and bioﬁlms) a large number of cells will die while some
will survive. Over the course of the treatment, antibiotics will
be present at different concentrations at different times and sites
and therefore mediating different types of interactions with viable
bacterial cells. At subinhibitory concentrations, antibiotics will
induce different biological responses, for which antibiotic resis-
tance/tolerance will subsequently be affected. In this particular
polymicrobial community, β-lactams will induce the release of
eDNA from S. aureus in an autolysin-dependent manner and
FIGURE 5 | Metabolite-mediated interactions modulating antibiotic
resistance or tolerance in polymicrobial communities. Following an
antibiotic treatment, natural communities will respond, adapt, and evolve
through the establishment of dynamic interactions mediated by antibiotics
and non-antibiotic metabolites. A simple polymicrobial community comprising
P. aeruginosa (green), S. aureus (purple), and Streptococcus spp. (brown) is
used to illustrate this hypothetical scenario. A proportion of the established
community, made of multispecies bioﬁlms and planktonic cells, will die and
subsequently lyse upon antibiotic exposure, unless
cells harbor the corresponding antibiotic resistance determinant (capped
cells; red, blue, or orange corresponding to the respective antibiotic)
or are part of multicellular structures (bioﬁlms, aggregates). Subinhibitory
antibiotics and non-antibiotic metabolites within the community can
subsequently induce different antibiotic tolerance mechanisms leading
to an altered community in terms of composition and antibiotic
resistance/tolerance.
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triggering bioﬁlm formation as a growth protective mechanism
(Kaplan et al., 2012). At the same time, subinhibitory concentra-
tions of other antibiotics will induce the production of pyocyanin
in P. aeruginosa (Shen et al., 2008) resulting in the generation
of H2O2, cell lysis, and subsequent release of more eDNA (Das
and Maneﬁeld, 2012). Streptococci bacteria are known to gen-
erate H2O2 causing cell lysis and the release of eDNA (Shen
et al., 2008). The accumulation of eDNA, through antibiotic and
non-antibiotic interactions, will chelate cations and primarily the
reduced cation concentrations that are directly sensed by the cells
leading to antibiotic tolerance (Mulcahy et al., 2008). In addition,
the community would favor bioﬁlms and aggregates as modes of
growth (Kaplan et al., 2012), which are generally more tolerant to
antibiotics.
The concentration of antibiotics will gradually decrease over
time allowing the remaining viable bacterial cells to grow back.
The CF lung is rich in amino acids (Palmer et al., 2007) and
actively growing bacteria will release ammonia as a by-product
of amino acid catabolism. Ammonia sensing by bacteria within
the community will induce the synthesis of polyamines leading to
increased tolerance against ampicillin and tetracycline (Bernier
et al., 2011) and oxidative stress (Bernier et al., 2011; Johnson
et al., 2012). Further, the CF lung itself is rich in extracellular
polyamines (Grasemann et al., 2012), which could directly affect
the antibiotic tolerance proﬁle of the community (El-Halfawy
and Valvano, 2012) independently of ammonia sensing. Fur-
ther, the consequences of these responses may impact syntrophic
and other metabolite-mediated interactions that can further alter
community composition.
For bacterial species that are naturally competent, the abun-
dance of eDNA may also represent an excellent source of antibi-
otic resistance genes. Subinhibitory antibiotics induce the SOS
response and competence systems (Charpentier et al., 2012) in
Streptococci leading to horizontal gene transfer and the acqui-
sition of resistance genes. Thereafter, the new-acquired resistance
genewill be transferred vertically through bacterial division result-
ing in a new drug-resistant Streptococci strain. Further, mutation
rates are also increased in all bacteria upon antibiotic exposure
leading to the generation of potential new drug-resistant mutants.
Resistance mechanisms that chemically inactivate antibiotics also
have the potential to reduce the concentration to subinhibitory
levels for susceptible cells in the community.
Through various inducible mechanisms mediated by antibi-
otics and non-antibiotic metabolites, the overall composition of
the community may change over time. This complex network of
interactions is not reﬂected in standard antibacterial susceptibil-
ity and these processes likely contribute to the frequent failure of
antibiotics to reduce the population of susceptible organisms in
patients. This will be more likely to occur in polymicrobial infec-
tions or when pathogens are part of a normal host community
such as in upper respiratory or gastrointestinal infections.
CONCLUSIONS AND PERSPECTIVES
The increase of antibiotic-resistant pathogens represents a very
signiﬁcant threat and challenge in the ﬁght against infectious
diseases. The complexity of the antibiotic resistome demon-
strates that antibiotic resistance will always be a menace even for
synthetic antibiotics. Fluoroquinolones represent a good example
of synthetic drugs against which bacteria have quickly evolved
resistance (Ruiz, 2003; D’Costa et al., 2006, 2007). More judicious
use of antibiotics clinically and restricting non-medical applica-
tions may slow down the spread of drug-resistant bacteria and the
emergence of new antibiotic-resistant pathogens, but the breadth
of the antibiotic resistome and the capacity of microbes to rapidly
evolve will make this an ongoing struggle. The chemical warfare
that has been going on in microbial communities for hundreds
of millions of years is something of a double-edged sword. Most
antibiotics in use today have a microbial origin. Microbial sec-
ondary metabolites have also been a valuable source of drugs not
restricted to just antibiotics. At the same time these communi-
ties have evolved complex resistance mechanisms that can rapidly
spread from natural environments to the clinic.
Since most antibiotics are natural molecules involved in chem-
ical interactions between bacteria in communities, it has become
important to expand our understanding of the effects of these
interactions on bacterial behaviors including antibiotic resistance.
Because the presence of subinhibitory antibiotics can result in
a phenotype, the responses are subject to evolution and natural
selection, the same as toxic interactions. In this review, we have
discussed and presented various scenarios on how antibiotics at
subinhibitory concentrations have the potential to induce different
biological responses leading to a generalmodiﬁcation in the antibi-
otic resistance proﬁles of both environmental and host-associated
bacteria. These non-lethal interactions can act as stress inducers or
be sensed as cues by receiver bacteria. Activation of the SOS stress
response by antibiotics appears to reduce the efﬁcacy of antibiotic
treatments and facilitate the evolution of resistance. Therefore,
new therapeutic strategies targeting the SOS response may in
return increase antibiotic efﬁcacy. Blocking the LexA cleavage,
therefore the SOS response, reduces the ability of E. coli to develop
resistance toward ciproﬂoxacin and rifampicin both in vivo and
in vitro, through mutations (Cirz et al., 2005). This suggests that
suppressing the SOS response would inhibit mutation rate, which
is an important downstream SOS-associated phenotype involved
in bacterial evolution and antibiotic resistance.
Manipulating cellular physiology has the potential to enhance
the efﬁcacy of antibiotics even in resistant strains. A recent study
explored this possibility and reported that an engineered bacte-
riophage targeting the SOS response network enhanced the killing
efﬁcacy of bactericidal antibiotics and survival in mice (Lu and
Collins, 2009). The enhanced antibiotic killing by SOS-targeting
phages was also effective against persister and bioﬁlm bacteria (Lu
and Collins, 2009).
The nature of the effect of volatile ammonia on antibiotic
resistance is dependent on the class of antibiotic. While bac-
terial exposure to volatile ammonia induces tolerance against
β-lactam and tetracycline antibiotics it increases the efﬁcacy of
aminoglycosides (Bernier et al., 2011). Interestingly, reactivation
of the metabolism of E. coli persisters by the addition of vari-
ous metabolites (glucose, mannitol, fructose, pyruvate) restored
their sensitivity to aminoglycosides to a level comparable to non-
persister cells (Allison et al., 2011). These two studies demonstrate
the proof of concept that bacterial interactions occurring in
natural communities via non-antibiotic molecules have the ability
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to increase antibiotic efﬁcacy. Non-antibiotic metabolites like
ammonia or glucose could be considered as antibiotic potentia-
tors in synergistic drug combination therapies. The combinations
of antibiotics and non-antibiotic drugs were showed to enhance
antimicrobial efﬁcacy against multidrug-resistant bacteria in both
in vivo and in vitro suggesting that synergistic drug combinations
have therapeutic potentials (Ejim et al., 2011).
Furthering our understanding of bacterial interactions medi-
ated by antibiotics andnon-antibioticmoleculeswill be valuable in
the development of new strategies to combat antibiotic resistance.
Although signiﬁcant ﬁndings have been made in this emerging
area of research, we need to further expand our views of these
dynamic interactions in microbial communities. The conven-
tional approach of determining in vitro susceptibilities to isolated
organisms has many limitations clinically and in polymicrobial
infections, many community interactions can reduce antibiotic
efﬁcacy in addition to traditional resistance mechanisms. Under-
standing chemical interactions within microbial communities
should include the role of antibiotics in these communities
and mechanisms of resistance. This will provide new oppor-
tunities and strategies to accelerate the discovery of bioactive
molecules. Finally, we have to continue our efforts toward our
global understanding of these non-classical views of antibiotic-
mediated resistance mechanisms as complementary and potential
strategies to new drug development programs in order to control
and adequately manage the spread of antibiotic resistance in the
future.
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